
Three-Month Treatment for Latent Tuberculosis Infection (LTBI) with Rifapentine and INH (R&I) in a Medical Center Employee Health Service (EHS): Strategy and Advantages
Author(s) -
W. Schneider,
Cynthia Eisenstein,
Susan K. Seo,
Sherard Lacaille,
Maria Del Castillo Garcia,
Esther Arguello Perez,
Fabián Andrés Rosas Romero,
Anabella Lucca Bianchi,
Sejal Morjaria,
Susan Murillo,
Arthur E. Brown
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.206
Subject(s) - rifapentine , medicine , latent tuberculosis , center (category theory) , isoniazid , tuberculosis , mycobacterium tuberculosis , intensive care medicine , family medicine , pathology , chemistry , crystallography